Inhibitory effect of ibudilast (KC-404) on the expression of the β2 integrin family on an eosinophilic cell line (EoL-1)

Annals of Allergy, Asthma and Immunology

Volumn 81, Issue 5 I, 1998, Pages 448-450

  Chihara, Junichi ^a   Urayama, Osamu ^a   Kayaba, Hiroyuki ^a   Honda, Kohei ^a   Saito, Norihiro ^a   Hayashi, Nobana ^b   Kurachi, Dai ^b   Yamamoto, Takahiro ^b  

^a AKITA UNIVERSITY   (Japan)

^b KINKI UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

CD11B ANTIGEN; CD18 ANTIGEN; CELL ADHESION MOLECULE; IBUDILAST; INTEGRIN; LYMPHOCYTE FUNCTION ASSOCIATED ANTIGEN 1; THROMBOCYTE ACTIVATING FACTOR;

ANTIINFLAMMATORY ACTIVITY; ARTICLE; CELL CULTURE; CONTROLLED STUDY; DRUG EFFECT; EOSINOPHIL; FLOW CYTOMETRY; HUMAN; HUMAN CELL; IMMUNOFLUORESCENCE; PRIORITY JOURNAL;

EID: 0031760927     PISSN: 10811206     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1081-1206(10)63144-4     Document Type: Article

References (27)

1. Prin L, Charon J, Capron M, et al. Heterogeneity of human eosinophils. II. Variability of respiratory burst activity related to cell density. Clin Exp Immunol 1984;57:735-742.
2. Pincus SH, Schooley WR, Di Napoli AM, Broder S. Metabolic heterogeneity of eosinophils from normal and hypereosinophilic patients. Blood 1981; 58:1175-1181.
3. Capron M, Spiegelberg HL, Prin L, et al. Role of IgE receptors in effector function of human eosinophils. J Immunol 1984;132:462-468.
4. Chihara J, Plumas J, Gruart V, et al. Characterization of a receptor for IL-5 on human eosinophils; Variable expression and induction by GM-CSF. J Exp Med 1990;172:1347-1351.
5. Capron M, Capron A, Dessaint JP, et al. Fc receptors for IgE on human and rat eosinophils. J Immunol 1981;126: 2087-2092.
6. Capron M, Kazatchkine MD, Fischer E, et al. Functional role of the alpha-chain of complement receptor type 3 in human eosinophil-dependent antibody-mediated cytotoxicity against achistosomes. J Immunol 1987;139:2059-2065.
7. Capron M. Eosinophils: receptors and mediators in hypersensitivity. Clin Exp Allergy 1989;19(Suppl 1):3-8.
8. Capron M. Epsinophils in diseases: receptors and mediators. In: Pichler MJ, ed. Progress in Allergy and Clinical Immunology. Toronto: Hogrefe & Huber Publishers, 1989:6-11.
9. Gleich GJ, Adolphson CR. The eosinophilic leukocyte. Adv Immunol 1986; 39:77-125.
10. Kay AB. Eosinophils in immunological reactions. Clin Exp Allergy 1987; 117:251-254.
11. Tomassini M, Tsicopoulous A, Tai PC, et al. Release of granule proteins by eosinophils from allergic and nonallergic patients with eosinophilia on immunoglobulin-dependent activation. J Allergy Clin Immunol 1991;88: 365-375.
12. Gruart V, Balloul JM, Prin L, et al. Variations in protein expression related to human eosinophil heterogeneity. J Immunol 1989;142:4416-4421.
13. Calderon E, Lockey RF. A possible role for adhesion molecules in asthma. J Allergy Clin Immunol 1992;90:853-865.
14. Wegner CD, Gundel RH, Relly P, et al. Intercellular adhesion molecule-1 (ICAM-1) in the pathogenesis of asthma. Science 1990;247:456-459.
15. Chihara J, Kurachi D, Yamamoto T, et al. High intensive expression of adhesion molecules on hypodense eosinophils. Eur Respir J 1992;5(Suppl 15): 187.
16. Saito H, Bourinbaiar A, Ginsburg M, et al. Establishment and characterization of a new eosinophilic leukemia cell line. Blood 1985;66:1233-1240.
17. Chihara J, Gruart V, Plumas J, et al. Induction of CD23, CD25 and CD4 expression on EoL-3 by IL-3, GM-CSF and IL-5. Eur Cytokines Net 1992;3:53-61.
18. Kawasaki A, Hoshino K, Osaki R, et al. Effect of ibudilast: A novel anti-asthmatic agent, on airway hypersensitivity in bronchial asthma. J Asthma 1992;29:245-252.
19. Ohashi M, Kanai R, Nishino K, et al. Antagonistic effect of KC-404, a new anti-asthmatic guinea-pig smooth muscles. Prostaglandins 1986;32:875-888.
20. Souness JE, Villamil ME, Scott LC, et al. Possible role of cyclic AMP phosphodiesterases in the actions of ibudilast on eosinophil thromboxane generation and airways smooth muscle tone. Br J Pharmacol 1994;111:1081-1088.
21. Chihara J, Kakazu T, Higashimoto I, et al. Increased eosinophil oxidative metabolism by treatment with soluble intercellular adhesion molecule-1. Int Arch Allergy Immunol 1995; 108(Suppl 1):45-47.
22. Chihara J, Yamamoto T, Kurachi D, et al. Possible release of eosinophil granule proteins in response to signaling from intercellular adhesion molecule-1 and its ligands. Int Arch Allergy Immunol 1995;108(Suppl 1):52-54.
23. 2 integrin expression on an eosinophilic cell line (EoL-1) by the supernatant of mononuclear cells stimulated with specific allergen from asthmatic patients. Immunol Lett 1994;42:25-29.
24. Chihara J, Nakajima S. Platelet factor 4 has chemotactic activity for eosinophils and augments Fc γ and Fc ε receptor expression on eosinophils. In: Morley J, Colditz I, eds. Perspectives in asthma, eosinophils in asthma. London: Academic Press, 1989:151-156.
25. Warringa RAJ, Schweizer RC, Maikoe T, et al. Modulation of eosinophil chemotaxis by interleukin-5. Am J Respir Cell Mol Biol 1992;7:631-636.
26. Chihara J, Oyamada H, Yamada H, et al. Expression of mRNA for RANTES in human eosinophils. Int Arch Allergy Immunol 1997;(Suppl 1):33-35.
27. Chihara J, Yasuba H, Tsuda A, et al. Elevation of the plasma level of RANTES during asthma attacks. J Allergy Clin Immunol 1997;100:S52-55.